Advertisement
Screener

ARDELYX, INC. (ARDX) Graph

ARDX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $120.88M; Cost of revenue $5.76M; Research and development $26.10M; Selling, general and administrative $101.44M.
  • 2026-03-31: Revenue $94.47M; Cost of revenue $4.81M; Research and development $20.19M; Selling, general and administrative $102.27M.
  • 2025-12-31: Revenue $125.22M*; Cost of revenue $10.85M*; Research and development $22.86M*; Selling, general and administrative $86.41M*.
  • 2025-09-30: Revenue $110.33M; Cost of revenue $3.98M; Research and development $18.07M; Selling, general and administrative $83.61M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ARDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License$96.00KProduct$118.13MNon Cash Royalty Related ToSale Of Future Royalties$676.00KProduct IBSRELA$86.24MProduct Supply Revenue$1.98MProduct XPHOZAH$31.89MRevenue$120.88MCost of revenue$5.76MOperating income-$12.42MResearch & development$26.10MSelling, general& administrative$101.44MPre-tax income-$16.61MIncome tax$110.00KNet income-$16.72M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

ARDX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$120.88MRevenue$120.88MCost of revenue$5.76MOperating income-$12.42MResearch & development$26.10MSelling, general& administrative$101.44MPre-tax income-$16.61MIncome tax$110.00KNet income-$16.72M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$120.88M$5.76M$26.10M$101.44M(m)$110.00K-$16.72M
2026-03-31$94.47M$4.81M$20.19M$102.27M(m)$8.00K-$37.60M
2025-12-31$125.22M*$10.85M*$22.86M*$86.41M*(m)$7.00K*-$808.00K*
2025-09-30$110.33M$3.98M$18.07M$83.61M(m)$102.00K-$969.00K
2025-06-30$97.66M$12.40M$15.67M$83.99M(m)$1.00K-$19.08M
2025-03-31$74.11M$12.30M$14.94M$83.22M(m)$859.00K-$41.14M
2024-09-30$98.24M$15.73M$15.31M$64.97M(m)$43.00K-$809.00K
2024-06-30$73.22M$9.44M$12.76M$64.65M(m)$67.00K-$16.45M
2024-03-31$46.02M$7.13M$10.58M$52.99M(m)$121.00K-$26.52M
2023-09-30$56.39M$7.69M$8.64M$32.66M(m)$200.00K$6.63M
2023-06-30$22.33M$3.49M$8.28M$27.19M(m)$0.00-$17.12M
2023-03-31$11.37M$1.54M$9.09M$26.80M(m)$14.00K-$26.77M
2022-09-30$4.99M$732.00K$7.47M$18.67M(m)$0.00-$22.89M
2022-06-30$2.53M$138.00K$9.74M$18.86M(m)$6.00K-$26.94M
2022-03-31$468.00K$85.00K$8.85M$19.34M(m)$2.00K-$28.07M
2021-09-30$1.17M$0.00$23.70M$19.71M(m)$1.00K-$43.59M
2021-06-30$1.31M$0.00$26.02M$20.12M(m)$2.00K-$45.19M
2021-03-31$6.58M$1.00M$20.46M$17.13M(m)$1.00K-$33.16M
2020-12-31$1.81M(m)(m)(m)(m)(m)-$28.88M
2020-09-30$2.71M$0.00$12.24M(m)(m)$0.00-$18.11M
2020-06-30$1.84M$141.00K$18.86M(m)(m)$0.00-$24.96M
2020-03-31$1.21M$0.00$15.84M(m)$22.98M$0.00-$22.37M
2019-12-31$2.25M(m)(m)(m)$21.10M(m)-$19.79M
2019-09-30$3.01M$600.00K$17.58M(m)$24.50M$301.00K-$23.54M
2019-06-30$18.00K(m)$19.48M(m)$24.85M(m)-$25.47M
2019-03-31(m)(m)$20.38M(m)$25.50M$2.00K-$26.14M
2018-12-31$85.00K(m)(m)(m)$27.46M(m)-$27.86M
2018-09-30$172.00K$2.00K$17.94M(m)$23.90M(m)-$24.13M
2018-06-30$30.00K(m)$16.05M(m)$22.18M$2.00K-$22.29M
2018-03-31$2.32M$464.00K$13.35M(m)$19.54M$4.00K-$17.02M
2017-12-31$42.00M(m)(m)(m)$22.64M(m)$10.11M
2017-09-30(m)(m)$15.37M(m)$21.23M$0.00-$20.72M
2017-06-30(m)(m)$20.57M(m)$26.42M$0.00-$25.72M
2017-03-31(m)(m)$22.39M(m)$28.43M$0.00-$28.01M
2016-12-31(m)(m)(m)(m)$31.48M(m)-$31.28M
2016-09-30(m)(m)$24.86M(m)$29.20M$0.00-$29.03M
2016-06-30(m)(m)$23.84M(m)$28.69M$0.00-$28.61M
2016-03-31(m)(m)$19.25M(m)$23.53M$0.00-$23.47M
2015-12-31(m)(m)(m)(m)$16.88M(m)-$17.00M
2015-09-30(m)(m)$14.71M(m)$18.08M-$30.00K-$18.13M
2015-06-30$18.14M(m)$6.20M(m)$9.09M$0.00$9.01M
2015-03-31$5.88M(m)$6.20M(m)$9.37M$0.00-$3.50M
2014-12-31$6.34M(m)(m)(m)$10.27M(m)-$3.97M
2014-09-30$7.60M(m)$5.69M(m)$7.52M(m)$74.00K
2014-06-30$9.14M(m)$5.18M(m)$6.39M$0.00$3.75M
2014-03-31$8.55M(m)$7.64M(m)$9.01M$0.00-$3.07M
2013-12-31$8.49M(m)(m)(m)$9.21M(m)-$4.27M
2013-09-30$6.59M(m)$6.58M(m)$7.48M$35.00K-$934.00K
2013-06-30$7.29M(m)$7.23M(m)$8.14M$36.00K-$891.00K
2013-03-31$6.56M(m)(m)(m)$6.97M(m)-$470.00K

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$215.35M$10.57M$46.29M$203.71M(m)$118.00K-$54.33M
2025-06-30$171.78M$24.71M$30.60M$167.21M(m)$860.00K-$60.22M
2024-06-30$119.25M$16.56M$23.34M$117.65M(m)$188.00K-$42.97M
2023-06-30$33.70M$5.03M$17.38M$53.99M(m)$14.00K-$43.89M
2022-06-30$2.99M$223.00K$18.59M$38.20M(m)$8.00K-$55.01M
2021-06-30$7.89M$1.00M$46.48M$37.26M(m)$3.00K-$78.34M
2020-06-30$3.05M$141.00K$34.71M(m)(m)$0.00-$47.33M
2019-06-30$18.00K(m)$39.86M(m)$50.34M$2.00K-$51.61M
2018-06-30$2.35M$464.00K$29.40M(m)$41.73M$6.00K-$39.31M
2017-06-30(m)(m)$42.96M(m)$54.85M$0.00-$53.73M
2016-06-30(m)(m)$43.09M(m)$52.22M$0.00-$52.08M
2015-06-30$24.03M(m)$12.40M(m)$18.46M$0.00$5.50M
2014-06-30$17.69M(m)$12.82M(m)$15.40M$0.00$682.00K
2013-06-30$13.85M(m)$13.17M(m)$15.11M$71.00K-$1.36M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$282.11M$28.69M$48.67M$250.82M(m)$962.00K-$61.19M
2024-09-30$217.49M$32.29M$38.65M$182.62M(m)$231.00K-$43.78M
2023-09-30$90.09M$12.72M$26.01M$86.65M(m)$214.00K-$37.27M
2022-09-30$7.98M$955.00K$26.06M$56.87M(m)$8.00K-$77.90M
2021-09-30$9.07M$1.00M$70.17M$56.97M(m)$4.00K-$121.93M
2020-09-30$5.76M$141.00K$46.95M(m)(m)$0.00-$65.44M
2019-09-30$3.03M$600.00K$57.44M(m)$74.85M$303.00K-$75.15M
2018-09-30$2.52M$466.00K$47.34M(m)$65.63M$6.00K-$63.44M
2017-09-30(m)(m)$58.33M(m)$76.08M$0.00-$74.45M
2016-09-30(m)(m)$67.95M(m)$81.42M$0.00-$81.11M
2015-09-30$24.03M(m)$27.10M(m)$36.54M-$30.00K-$12.62M
2014-09-30$25.28M(m)$18.51M(m)$22.91M(m)$757.00K
2013-09-30$20.44M(m)$19.76M(m)$22.59M$106.00K-$2.29M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$407.32M$39.54M$71.53M$337.23M(m)$969.00K-$62.00M
2024-12-31$333.62M$50.56M$52.32M$258.69M(m)$266.00K-$39.00M
2023-12-31$124.46M$17.80M$35.54M$134.40M(m)$547.00K-$66.00M
2022-12-31$52.16M$4.12M$35.20M$76.60M(m)$8.00K-$67.00M
2021-12-31$10.10M$1.00M$91.14M$72.30M(m)$4.00K-$158.00M
2020-12-31$7.57M$145.00K$65.05M(m)(m)$2.00K-$94.31M
2019-12-31$5.28M$600.00K$71.68M(m)$95.94M$303.00K-$94.94M
2018-12-31$2.61M$466.00K$69.37M(m)$93.09M$4.00K-$91.30M
2017-12-31$42.00M$8.40M$75.48M(m)$98.72M$1.18M-$64.34M
2016-12-31(m)(m)$94.16M(m)$112.89M(m)-$112.39M
2015-12-31$24.03M(m)$39.88M(m)$53.41M-$29.00K-$29.62M
2014-12-31$31.62M(m)$25.90M(m)$33.19M$67.00K-$3.21M
2013-12-31$28.93M(m)$28.09M(m)$31.79M$141.00K-$6.56M
2012-12-31$5.41M(m)$10.18M(m)$14.21M(m)-$9.79M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Apnimed, Inc. (APMD)United States$0.899B
GERON CORP (GERN)United States$0.803B-12.14